筋肉内ドラッグデリバリーの世界市場及びパイプライン分析...市場調査レポートについてご紹介

1. Introduction to Intramuscular Drug Delivery

2. Overview of Different Drug Delivery Mechanisms

3. Intramuscular Drug Delivery Mechanism
3.1 Mechanism Overview
3.2 Intramuscular Drug Delivery Devices

4. Global Intramuscular Drug Delivery Market Outlook
4.1 Market Overview
4.2 Intramuscular Drug Delivery Pipeline Overview

5. Global Intramuscular Drug Delivery Market Dynamics
5.1 Favorable Market Parameters
5.2 Challenges

6. Intramuscular Drug Delivery Market Future Prospects

7. Intramuscular Drug Pipeline by Company, Country, Indication & Phase
7.1 Research
7.2 Preclinical
7.3 Clinical
7.4 Phase-0
7.5 Phase-I
7.6 Phase-I/II
7.7 Phase-II
7.8 Phase-II/III
7.9 Phase-III
7.10 Preregistration
7.11 Registered

8. Marketed Intramuscular Drugs by Company, Country & Indication

9. Discontinued & Suspended Intramuscular Drugs in Clinical Pipeline
9.1 No Development Reported
9.2 Discontinued
9.3 Market Withdrawal
9.4 Suspended

10. Competitive Landscape
10.1 Antares Pharma
10.2 Eli Lily
10.3 Galaxo
10.4 HMD pharmaceuticals
10.5 Inovio Pharmaceuticals
10.6 Merck
10.7 Novartis
10.8 Pacira Pharmaceuticals
10.9 Pfizer
10.10 Pharmajet
10.11 Teva Pharmaceutical

Figure 1-1: Site of Intramuscular Drug Delivery
Figure 1-2: Various Methods of Drug Delivery
Figure 1-3: Features of Intramuscular Drug Delivery System
Figure 1-4: Classification of Human Muscular System
Figure 1-5: Intramuscular Drug Delivery Sites for Administration
Figure 1-6: Technical Issues with Intramuscular Drug Delivery
Figure 3-1: Factors Affecting Intramuscular Drug Activity
Figure 3-2: Mechanism of Intramuscular Drug Delivery
Figure 3-3: Properties of Intramuscular Drug Delivery
Figure 4-1: Intramuscular Pipeline by Phase (%), 2015
Figure 4-2: Intramuscular Pipeline by Phase (Numbers), 2015
Figure 4-3: No Development Reported Intramuscular Pipeline by Phase (%), 2015
Figure 4-4: No Development Reported Intramuscular Pipeline by Phase (Numbers), 2015
Figure 4-5: Discontinued Intramuscular Pipeline by Phase (%), 2015
Figure 4-6: Discontinued Intramuscular Pipeline by Phase (Numbers), 2015
Figure 4-7: Suspended Intramuscular Pipeline by Phase (%), 2015
Figure 4-8: Suspended Intramuscular Pipeline by Phase (Numbers), 2015
Figure 5-1: Drivers for Intramuscular Drug Delivery Market
Figure 5-2: Challenges for Intramuscular Drug Delivery

Table 2-1: Overview of Different Drug Delivery Mechanisms
Table 3-1: Comparative Analysis of Intramuscular Drug Delivery Devices